Form 4: BioLargo Director Bray Receives Options as Compensation for Board Service

Christina Elaine Bray, a director at BioLargo, Inc. (BLGO), received options to purchase 53,571 shares of common stock as compensation for board service.

Summary

• On March 31, 2024, Christina Elaine Bray, a director of BioLargo, Inc., was granted an option to purchase 53,571 shares of the company's common stock.
• The options were issued as payment for $18,750 in fees for board services during the most recent quarterly period.
• The exercise price of the options is $0.35 per share.
• The options were granted pursuant to BioLargo's 2018 Equity Incentive Plan.
• Following the transaction, Bray directly owns options to purchase 639,282 shares of BioLargo common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The granting of options is a standard practice and aligns the director's interests with shareholders. There are no overtly negative aspects presented in the document.

Positives

• The issuance of options aligns the director's interests with those of the shareholders.
• The options serve as compensation for board service, conserving the company's cash resources.

Future Outlook

There is no future outlook provided in this document.

Industry Context

This is a standard practice for compensating board members, particularly in smaller companies, to conserve cash.

Comparison to Industry Standards

• Granting stock options to board members is a common practice, especially for companies looking to conserve cash.
• The specific amount and terms of the options would need to be compared to similar companies in the environmental technology sector to determine if they are in line with industry standards.
• Companies like Xylem, Inc. or Danaher Corporation, while much larger, also utilize equity compensation for their board members, though the scale is significantly different.

Related Party Transactions

• The granting of options to Christina Elaine Bray, a director, is a related party transaction.

Stakeholder Impact

• Shareholders may view the option grant as a positive, aligning the director's interests with the company's performance.
• The company conserves cash by compensating the director with options instead of cash payments.

Key Dates